These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32878809)
21. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy. Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694 [TBL] [Abstract][Full Text] [Related]
22. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway. Lu C; Jia S; Zhao S; Shao X Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667 [TBL] [Abstract][Full Text] [Related]
23. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis. Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032 [TBL] [Abstract][Full Text] [Related]
24. Daucosterol Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Wnt/β-Catenin Signaling. Zeng J; Liu X; Li X; Zheng Y; Liu B; Xiao Y Molecules; 2017 Jun; 22(6):. PubMed ID: 28574485 [TBL] [Abstract][Full Text] [Related]
25. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993 [TBL] [Abstract][Full Text] [Related]
26. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene. Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040 [TBL] [Abstract][Full Text] [Related]
27. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434 [TBL] [Abstract][Full Text] [Related]
28. LRP16 prevents hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling. Shao L; Jing W; Wang L; Pan F; Wu L; Zhang L; Yang P; Hu M; Fan K J Mol Med (Berl); 2018 Jun; 96(6):547-558. PubMed ID: 29748698 [TBL] [Abstract][Full Text] [Related]
29. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517 [TBL] [Abstract][Full Text] [Related]
30. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma. Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980 [TBL] [Abstract][Full Text] [Related]
31. Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma. Huang Y; Peng M; Yu W; Li H Int Immunopharmacol; 2024 Sep; 138():112534. PubMed ID: 38941667 [TBL] [Abstract][Full Text] [Related]
32. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma. Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261 [TBL] [Abstract][Full Text] [Related]
33. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Yamashita T; Budhu A; Forgues M; Wang XW Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828 [TBL] [Abstract][Full Text] [Related]
34. 6-C-(E-Phenylethenyl)Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling. Kang Q; Gong J; Wang M; Wang Q; Chen F; Cheng KW J Agric Food Chem; 2019 Dec; 67(50):13939-13947. PubMed ID: 31769973 [TBL] [Abstract][Full Text] [Related]
35. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806 [TBL] [Abstract][Full Text] [Related]
36. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma? Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516 [TBL] [Abstract][Full Text] [Related]
37. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Lu WJ; Chua MS; Wei W; So SK Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353 [TBL] [Abstract][Full Text] [Related]
38. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Lim K; Han C; Dai Y; Shen M; Wu T Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling. Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038 [TBL] [Abstract][Full Text] [Related]